topic

P02.02 Spectral flow cytometry reveals immune regulation of detailed lymphocyte and myeloid populations in neuroblastoma
AL Borst, MM van Noesel, JJ Molenaar, J Wienke

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A13; DOI: 10.1136/jitc-2024-ITOC10.22
P02.05 AATF(Che-1) RNA polymerase II binding protein overexpression in BCP-ALL cells controls NK-cell proliferation through IL15 expression
M Caforio, N Tumino, C Sorino, S Di Giovenale, L Moretta, M Fanciulli, P Vacca, F Locatelli, V Folgiero

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A14; DOI: 10.1136/jitc-2024-ITOC10.24
P02.06 Integrated multi-omics unraveled a basal cell-dependent signature predictor of outcome and immunotherapy response in LUSC
J Jia, R Liu, B Deng, X Guo, L Trassl, GA Giotopoulou, SJ Behrend, Y Liu, AÖ Yildirim, GT Stathopoulos, AC Schamberger, IE Fernandez

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A14-A15; DOI: 10.1136/jitc-2024-ITOC10.25
P02.09 Correlation of NK cell activity depending on TNF receptor expression on stem cells
V Jurisic

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A16; DOI: 10.1136/jitc-2024-ITOC10.28
P02.08 Immune-related protein changes due to standard of care therapy in recurrent ovarian cancer patients
J Kempeneers, J Ceusters, G Thirion, S Claes, D Schols, T Baert, A Coosemans

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A16; DOI: 10.1136/jitc-2024-ITOC10.27
P02.14 High-plex co-detection of RNA and protein to explore tumor-immune interactions utilizing RNAscope with imaging mass cytometry
A-S Thomas-Claudepierre, J Pemberton, S Kala, A Dikshit, C Hupple

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A18; DOI: 10.1136/jitc-2024-ITOC10.33
P03.01 Efficacy and toxicity of BCG therapy in bladder cancer
S Acharya

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A19; DOI: 10.1136/jitc-2024-ITOC10.34
03.05 DSP216 blocks HLA-G and CD47 signaling toward immune cells and restores anti-cancer activity
LJ Jacob

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A2; DOI: 10.1136/jitc-2024-ITOC10.3
03.06 Cancer-specific oral microbiotherapy for cancer immunotherapy
C-x Pan, V Reddy Chittepu, Z Zhu, C Yang, L Sun, A-H Ma, S Wang, R Curtiss

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A2-A3; DOI: 10.1136/jitc-2024-ITOC10.4
P04.01 Early recovery of radiation induced lymphopenia in NSCLC stage III lung cancer: correlation with prognosis in a prospective study
T Hofer, AE Nieto, L Kaesmann, CJ Pelikan, J Taugner, S Mathur, C Eze, C Belka, F Manappov, E Noessner

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A20; DOI: 10.1136/jitc-2024-ITOC10.36

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages